Back
Liquidia Corp. 10K Form
Buy
69
LQDA
Liquidia Corp.
Last Price:
$33.92
Seasonality Move:
28.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | LQDA/Liquidia Corp. Quarterly |
| 2020-05-11 | 10Q | LQDA/Liquidia Corp. Quarterly |
| 2020-03-16 | 10K | LQDA/Liquidia Corp. Annual |
| 2019-11-13 | 10Q | LQDA/Liquidia Corp. Quarterly |
| 2019-08-14 | 10Q | LQDA/Liquidia Corp. Quarterly |
| 2019-05-02 | 10Q | LQDA/Liquidia Corp. Quarterly |
Receive LQDA News And Ratings
See the #1 stock for the next 7 days that we like better than LQDA
LQDA Financial Statistics
Sales & Book Value
| Annual Sales: | $14M |
|---|---|
| Cash Flow: | $-10.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.25 |
| Price / Book: | 133.1 |
Profitability
| EPS (TTM): | -1.43030 |
|---|---|
| Net Income (TTM): | $-121.8M |
| Gross Margin: | $6.8M |
| Return on Equity: | -221.75% |
| Return on Assets: | -48.86% |
Liquidia Corp. Earnings Forecast
Key Liquidia Corp. Financial Ratios
-
The Gross Profit Margin over the past 9 years for LQDA is 48.73%.
-
The Selling, General & Administrative Expenses for LQDA have been equal to 582.80% of Gross Profit Margin.
-
The Research & Development expenses have been 332.56% of Revenue.
-
The Net Earning history of LQDA is -931.65% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Liquidia Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LQDA |
| CUSIP: | 53635D |
| Website: | liquidia.com |
Debt
| Debt-to-Equity Ratio: | 9.03 |
|---|---|
| Current Ratio: | 2.2 |
| Quick Ratio: | 1.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.01 |
LQDA Technical Analysis vs Fundamental Analysis
Buy
69
Liquidia Corp. (LQDA)
is a Buy
Is Liquidia Corp. a Buy or a Sell?
-
Liquidia Corp. stock is rated a BuyThe current Liquidia Corp. [LQDA] share price is $33.74. The Score for LQDA is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.